For the first time in a decade, there’s a whiff of real fear in the financial markets.  I’m not talking about the low-grade anxiety we’ve seen occasionally during the bull market, where investors worry about when to buy the dip. Over the last few days we’ve seen something different -- a deeper fear, fear that comes from not knowing if there is a bottom.
Spirit Air insider Christine Richards bought 5000 shares of the discount airline despite worries Coronavirus could impact global travel. Richards was appointed director at Spirit Airlines Inc. (SAVE) in Sept. of last year. A Form 4 filed today disclosed the purchase of $216K of SAVE at $43.24....
Many traders know of Bruce Kovner, the cab driver turned multi-billionaire, from his interview with Jack Schwager in the classic investment book Market Wizards. As founder and Chairman of Caxton Associates from 1983 to 2011, Kovner reportedly averaged 21% annual returns. Kovner managed as much as $14 billion...
Corporate insiders have proprietary information about their companies. That's why the SEC requires insiders -- officers, directors and 10% holders of any publicly traded company -- to disclose all trades in their own stocks. Insiders are prohibited from trading on “material, non-public information.” Nonetheless, many studies...
A three day (dead cat?) bounce propelled the S&P 500 over 13% higher last week, rescuing stocks, at least temporarily, from the worst stretch of performance since the dark days of 1929. During the Coronavirus crash over the last several weeks, stocks were liquidated indiscriminately, as investors...
Director Stephen Luczo bought $3.7 mil of AT&T(T) at $37.60 on Feb.4. It was Luczo's -- who is also Chairman of the Board at Seagate Technology(STX) -- first open market purchase of AT&T shares since becoming a director in November. Luczo's history as a...
Intra-Cellular Therapies FDA news release on Sept. 10 appeared positive. The FDA informed the company that it will not schedule an Advisory Committee meeting in connection with its review of the company’s new drug application (NDA) for Lumateperone for the treatment of schizophrenia. All good, moving ahead,...
Stock market prognosticators are getting bearish. “We’re now in a bear market, get ready for lower prices…” a growing chorus of pessimistic “experts” are saying. “Watch out for the Death Cross!” Yikes. Of course, this great advice comes after the market has already tanked 10%. Where was this helpful advice in Sept. before things went south in a hurry?  
While the machines took over the stock market on Monday, relentlessly selling anything with a stock ticker, a few smart-money investors waded into the fray, using old fashioned fundamentals like earnings and valuations to inform their stock-picking. One of the value/contrarian buyers was Stephen M. Zide, who disclosed Monday evening the purchase of 20,000 shares of chemical producer Trinseo S.A.
Select Medical Insider buying has been historically rare. And It's been nearly a decade since Rocco Ortenzio purchased stock of Select Medical Holdings (SEM). But in a Form 4 filed on March 18, the Vice-Chairman and Co-Founder of the hospital operator disclosed a buy...